Viewing StudyNCT00350090



Ignite Creation Date: 2024-05-05 @ 4:58 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00350090
Status: TERMINATED
Last Update Posted: 2011-05-19
First Post: 2006-07-07

Brief Title: A Study to Assess the Response Rate of PROCRIT Epoetin Alfa Given at a Dose of 40000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy
Sponsor:
Organization: Ortho Biotech Products LP